[HTML][HTML] Blood-based kinase activity profiling: A potential predictor of response to immune checkpoint inhibition in metastatic cancer
DP Hurkmans, EME Verdegaal, SA Hogan… - … for ImmunoTherapy of …, 2020 - ncbi.nlm.nih.gov
Background Many cancer patients do not obtain clinical benefit from immune checkpoint
inhibition. Checkpoint blockade targets T cells, suggesting that tyrosine kinase activity …
inhibition. Checkpoint blockade targets T cells, suggesting that tyrosine kinase activity …